OrSense, a developer of monitors for non-invasive measurements of various blood parameters, has introduced NBM200, a non-invasive hemoglobin (Hb) measurement system for anemia screening and hemorrhage detection at the Global Forum of Maternal and Infant Health, at Barcelona, Spain.
OrSense has developed and commercialised NBM200, a portable point of care (POC) monitoring system for measuring spot and continuous hemoglobin and other blood parameters.
Being non invasive, it eliminates the need for finger prick and biochemistry based blood test, prevents infection risks and eliminates the need for handling bio-hazardous material.
OrSense claims that NBM200 offers an accurate, safe, fast, easy to operate and affordable solution that would allow for anemia screening and monitoring.
NBM200 is based on OrSense’s Occlusion Spectroscopy technology, which uses a non-invasive optical measurement platform combined with a ring-shaped pneumatic probe that fits on the finger and helps in early detection of post partum hemorrhage and improved blood management post delivery.
Helen Schneider Hospital for Woman director Moshe Hod said that the NBM200 has proven its accuracy and ease of use in determining Hb levels non-invasively and he believes that this device offers a much-needed viable solution for anemia screening and hemorrhage detection not only in hospitals and physician offices, but also in rural and community clinics throughout the world.